Experienced in Hairy Cell Leukemia (HCL)

Dr. Eric W. Dean

Oncology | Hematology
The Association Of University Physicians
825 Eastlake Ave E, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Experienced in Hairy Cell Leukemia (HCL)
The Association Of University Physicians
825 Eastlake Ave E, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eric Dean is an Oncologist and a Hematologist in Seattle, Washington. Dr. Dean is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Dean is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in WA
Hospital Affiliations
Evergreenhealth Monroe
University Of Washington Medical Ctr
Evergreenhealth Medical Center
Languages Spoken
English
Bengali
Filipino
German
Hindi
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

THE ASSOCIATION OF UNIVERSITY PHYSICIANS
825 Eastlake Ave E, Seattle, WA 98109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase II Study of Lenalidomide and Rituximab in Subjects with Previously Untreated Indolent Non Hodgkin's Lymphoma
Phase II Study of Lenalidomide and Rituximab in Subjects with Previously Untreated Indolent Non Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Rituximab, Lenalidomide
Study Phase: Phase 2
View 3 Less Clinical Trials

3 Total Publications

Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Journal: Nature communications
Published: December 10, 2015
Similar Doctors
David M. Aboulafia
Advanced in Hairy Cell Leukemia (HCL)
Dr. David M. Aboulafia
Hematology Oncology | Hematology | Oncology
Advanced in Hairy Cell Leukemia (HCL)
Dr. David M. Aboulafia
Hematology Oncology | Hematology | Oncology

Virginia Mason Medical Center

925 Seneca St, 
Seattle, WA 
 (1.1 miles away)
206-223-6600
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

David Aboulafia is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Aboulafia is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Non-Hodgkin Lymphoma, Anal Cancer, Kaposi Sarcoma, B-Cell Lymphoma, and Splenectomy. Dr. Aboulafia is currently accepting new patients.

Advanced in Hairy Cell Leukemia (HCL)
Dr. Nehal Masood
Hematology Oncology | Hematology | Oncology
Advanced in Hairy Cell Leukemia (HCL)
Dr. Nehal Masood
Hematology Oncology | Hematology | Oncology

Multicare Health System

317 Mlk Jr Way, Multicare Social Work Serv, 
Tacoma, WA 
 (26.1 miles away)
253-403-1126
Languages Spoken:
English, Castilian, Hindi, Mandarin, Spanish, Swedish, Tamil, Urdu, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Nehal Masood is a Hematologist Oncology specialist and a Hematologist in Tacoma, Washington. Dr. Masood is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Angiosarcoma. Dr. Masood is currently accepting new patients.

Advanced in Hairy Cell Leukemia (HCL)
Dr. Sirisha M. Jain
Hematology Oncology | Hematology | Oncology
Advanced in Hairy Cell Leukemia (HCL)
Dr. Sirisha M. Jain
Hematology Oncology | Hematology | Oncology

Franciscan Medical Group

19500 10th Ave Ne, Suite 100, 
Poulsbo, WA 
 (16.3 miles away)
360-598-7500
Languages Spoken:
English, Amharic, Portuguese, Russian, Spanish, Ukrainian, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Sirisha Jain is a Hematologist Oncology specialist and a Hematologist in Poulsbo, Washington. Dr. Jain is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jain is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dean's expertise for a condition
ConditionClose
      View All 24 Advanced Conditions
      View All 80 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile